Friday, December 05, 2014 10:04:14 AM
Sunday, 11/16/14 08:41:47 PM
Re: sjk2108 post# 8666
Post # of 11550
Looky, looky. I just got an e-mail response from Taylor Wilson at the Nebraska Medical Center. Sounds promising !! Maybe, just maybe!!
5:49 pm
Wilson, Taylor
To: Steve xxxxx
Thanks, Steve. We are aware of this device and our doctors are exploring the possibility of using it. Thanks for your interest.
Taylor Wilson
Senior Media Relations Coordinator
Nebraska Medicine
402-559-7037 (o)
402-871-8338 (c)
402-888-5479 (p)
www.NebraskaMed.com<www.NebraskaMed.com>
www.facebook.com/NebraskaMed<http://www.facebook.com/NebraskaMed>;
www.twitter.com/NebraskaMed<http://www.twitter.com/NebraskaMed>;
www.YouTube.com/NebraskaMed<http://www.YouTube.com/NebraskaMed>;
On Nov 16, 2014, at 4:36 PM, "sjk2108@xxxxxxxx.xxx<mailto:sjk2108@xxxxxxx.xxxx>" <sjk2108@xxxxx.xxxx<mailto:sjk2108@xxxxxx.xxxx>> wrote:
Name: Steve xxxxxx
E-mail Address: sjk2108@xxxxxx.xxx<mailto:sjk2108@xxxxxx.xxxx>
Phone Number: xxx-xxx-xxxx
Contact Type: Media / Public Relations
Message: Mr. Wilson, I am a shareholder in a small company called Aethlon Medical. Their medical device, called a hemopurifier, was just used on a Dr. Mawanda of Uganda who was also suffering from Ebola. This occurred in Germany. The results of this viral filtering device were just released this past Friday at the Kidney Week convention in Philadelphia. This patient was extremely sick with loss of many organ functions and was on dialysis. Once the filter was introduced, his viral load went down by 95% in a 6-1/2 hour treatment. After that, he recovered on his own once the viral load was removed from his body. Please look into this device for treating your new patient. It's a miracle worker. You can get more info by looking at the Aethlon Website. It will have all of the details you need. Thank you for your time.
Steve xxxxxx
Submitted at: 11/16/2014 4:35:36 PM
Recent AEMD News
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 11/15/2024 09:40:55 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2024 10:15:18 PM
- Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update • PR Newswire (US) • 11/13/2024 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 02:00:08 PM
- Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia • PR Newswire (US) • 11/11/2024 01:01:00 PM
- Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024 • PR Newswire (US) • 11/06/2024 01:01:00 PM
- Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit • PR Newswire (US) • 10/08/2024 12:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2024 08:44:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2024 09:00:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/01/2024 09:30:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/01/2024 09:30:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/01/2024 09:30:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2024 12:01:08 PM
- Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India • PR Newswire (US) • 09/19/2024 12:01:00 PM
- Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial • PR Newswire (US) • 09/16/2024 12:01:00 PM
- Aethlon Medical to Present at the Life Sciences Investor Forum September 19th • GlobeNewswire Inc. • 09/13/2024 12:35:00 PM
- Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys • PR Newswire (US) • 08/27/2024 12:01:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 08/15/2024 08:34:03 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/15/2024 08:32:05 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/15/2024 08:30:33 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 08/15/2024 08:15:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 09:10:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 08:15:21 PM
- Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update • PR Newswire (US) • 08/14/2024 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 12:01:08 PM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM